{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:51:07Z","timestamp":1789411867824,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jhepr.2024.101145","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:58:04Z","timestamp":1718308684000},"page":"101145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Implementing a new HCV model of care for people who use drugs"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-6415","authenticated-orcid":false,"given":"Andrea","family":"Herranz Mochales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila A.","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1841-8133","authenticated-orcid":false,"given":"Aina","family":"Nicol\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Maci\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Fern\u00e1ndez-Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-1205","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Trelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Sans\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia R.","family":"Rub\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Garc\u00eda-Gasalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4109-2350","authenticated-orcid":false,"given":"\u00c0ngels","family":"Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-2299","authenticated-orcid":false,"given":"Jeffrey V.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101145_bib1","unstructured":"World Health Organization. Hepatitis C: key facts, 2024. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c (Accessed 15 April 2024)."},{"key":"10.1016\/j.jhepr.2024.101145_bib2","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240053779 (Accessed 19 June 2023)."},{"key":"10.1016\/j.jhepr.2024.101145_bib3","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis, 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06 (Accessed 19 June 2023)."},{"key":"10.1016\/j.jhepr.2024.101145_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-01885-0","article-title":"Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review","volume":"11","author":"Picchio","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2024.101145_bib5","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide","volume":"142","author":"Maucort-Boulch","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2024.101145_bib6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/liv.14779","article-title":"Progress towards hepatitis C virus elimination in high-income countries: an updated analysis","volume":"41","author":"Gamkrelidze","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101145_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/liv.14796","article-title":"Absolute targets for HCV elimination and national health policy paradigms: foreseeing future requirements","volume":"41","author":"Kondili","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101145_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/joim.12972","article-title":"We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade","volume":"286","author":"Lazarus","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhepr.2024.101145_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/a-1777-6112","article-title":"A\u00a0global systematic review of hepatitis C elimination efforts through micro-elimination","volume":"42","author":"Lazarus","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2024.101145_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2024.101145_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination \u2013 a path to global elimination of hepatitis C","volume":"67","author":"Lazarus","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103320","article-title":"Conceptualising hepatitis C stigma: a thematic synthesis of qualitative research","volume":"96","author":"Harris","year":"2021","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035621","article-title":"Novel health systems service design checklist to improve healthcare access for marginalised, underserved communities in Europe","volume":"10","author":"Lazarus","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2024.101145_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1186\/s12889-023-16017-8","article-title":"Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs \u2013 a scoping review of the qualitative evidence","volume":"23","author":"Balsom","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhepr.2024.101145_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eimc.2020.03.004","article-title":"Hepatitis C reflex testing in Spain in 2019: a story of success","volume":"39","author":"Crespo","year":"2021","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jhepr.2024.101145_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102734","article-title":"Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain","volume":"80","author":"Saludes","year":"2020","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2020.114039","article-title":"Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis","volume":"289","author":"Mart\u00ednez-Campreci\u00f3s","year":"2021","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.jhepr.2024.101145_bib21","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhepr.2024.101145_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugpo.2019.01.012","article-title":"Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs","volume":"66","author":"Day","year":"2019","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101145_bib24","series-title":"Gu\u00eda de cribado de la infecci\u00f3n por el VHC","year":"2020"},{"key":"10.1016\/j.jhepr.2024.101145_bib25","series-title":"Objetivo 2021 | AEHVE - Alianza para la Eliminaci\u00f3n de las Hepatitis V\u00edricas en Espa\u00f1a","year":"2019"},{"key":"10.1016\/j.jhepr.2024.101145_bib26","first-page":"579","article-title":"Elimination of hepatitis C. Positioning document of the Spanish association for the study of the liver (AEEH)","volume":"42","author":"Crespo","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhepr.2024.101145_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053394","article-title":"Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care","volume":"11","author":"Lazarus","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2024.101145_bib28","article-title":"HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates","volume":"4","author":"Lens","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103134","article-title":"HCV screening based on dried blood samples and linkage to care in people who use drugs: a prospective study","volume":"92","author":"Ryan","year":"2021","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jvh.13634","article-title":"Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination","volume":"29","author":"Forns","year":"2022","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2024.101145_bib31","first-page":"550","article-title":"The contribution of telemedicine to hepatitis C elimination in a correctional facility","volume":"111","author":"Jim\u00e9nez","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhepr.2024.101145_bib32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis","volume":"7","author":"Cunningham","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib33","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S2468-1253(22)00275-8","article-title":"Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial","volume":"7","author":"Litwin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104185","article-title":"Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark","volume":"121","author":"Demant","year":"2023","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039724","article-title":"The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T\u2032N\u2032HepC)","volume":"10","author":"Lazarus","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2024.101145_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugpo.2019.06.021","article-title":"Point-of-care hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department","volume":"72","author":"Hutton","year":"2019","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2468-1253(19)30201-8","article-title":"Access to hepatitis C care for people who inject drugs and people in prisons","volume":"4","author":"Oru","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2019.07.016","article-title":"Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all","volume":"72","author":"Grebely","year":"2019","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jhepr.2024.101145_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2019.02.018","article-title":"Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy","volume":"71","author":"Mac\u00edas","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib41","first-page":"1","article-title":"Directly acting antiviral-based treatment for HCV-infected persons who inject drugs: a multicenter real-life study","volume":"11","author":"Messina","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jhepr.2024.101145_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28544","article-title":"Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat program","volume":"95","author":"Not","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2024.101145_bib43","first-page":"800","article-title":"Telemedicine improves HCV elimination among Italian people who use drugs: an innovative therapeutic model to increase the adherence to treatment into addiction care centers evaluated before and during the COVID-19 pandemic","volume":"11","author":"Rosato","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jhepr.2024.101145_bib44","series-title":"Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas","year":"2017"},{"key":"10.1016\/j.jhepr.2024.101145_bib46","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2018.06.016","article-title":"The removal of DAA restrictions in Europe \u2013 one step closer to eliminating HCV as a major public health threat","volume":"69","author":"Marshall","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101145_bib47","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2468-2667(21)00276-0","article-title":"100\u2013100\u2013100: a new, ambitious treatment target to end the HIV and hepatitis C epidemics","volume":"7","author":"Barocas","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jhepr.2024.101145_bib48","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cmi.2020.10.023","article-title":"Progression to hepatitis C virus micro-elimination in people living with HIV in Spain","volume":"27","author":"Rivero-Juarez","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhepr.2024.101145_bib49","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1002\/hsr2.191","article-title":"Toward microelimination of hepatitis C and HIV coinfection in NHS Tayside, Scotland: real-world outcomes","volume":"3","author":"Byrne","year":"2020","journal-title":"Health Sci Rep"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T23:19:24Z","timestamp":1728429564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2589555924001496"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101145","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing a new HCV model of care for people who use drugs","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101145"}}